H
Loading...
Loading...
CDC PLACES does not publish a city-level diabetes row for Lexington. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Census population 322,570. Kentucky Medicare wound biologics: CGS Administrators (J15). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Lexington clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Lexington storefront.
Fibrin Matrix Therapy Products in Lexington, KY for clinics & physicians. Fibrin matrix therapy supports w… Compliance support & pricing — contact Hawk Medical.
Copy-pasting a First Coast (Florida) LCD into a Kentucky chart is a denial pattern. You are J15. CDC PLACES does not publish a city-level diabetes row for Lexington. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Use Kentucky Cabinet for Health & Family Services for community education; use the IFU for the product in the fridge. fibrin matrix therapy is the SKU conversation, not a patient appointment book.
National Fibrin Matrix Therapy Products notes (how the product actually works)Kentucky shares J15 with OH. Florida is the only single-state MAC. CDC PLACES does not publish a city-level diabetes row for Lexington. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. If you also operate in another contractor’s state, say so on the first call — we map both.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Lexington trial. Local outcomes stay with the treating physician. CDC PLACES does not publish a city-level diabetes row for Lexington. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Use that rate for inventory math, not for ads.
CDC PLACES has no incorporated-place row we could match for Lexington. We will not interpolate one from the state BRFSS range. Use the national 12% (CDC) plus your panel.
It is the Census city-proper count — useful as scale for a city of 250k–500k. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Kentucky compliance risk.
Bring specialty, monthly wound volume, and whether you bill J15 FFS, Advantage, workers’ comp, or cash-pay. PLACES has no city row here; bring your own panel mix. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Lexington, KY.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Lexington is J15 geography and published epidemiology — not a street address.
No PLACES city row. National CDC 12% is the floor until you use your own panel.
Kentucky Part B wound biologics follow this contractor (siblings: OH). We train to the articles. We do not write coverage.
City-proper population is scale for a city of 250k–500k, not a count of orthopedic groups.
No Lexington storefront. Joe Bradley is an active practice owner. fibrin matrix therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.